PRESS RELEASE

Abbott and MSD Announce Strategic Partnership to Distribute Innovative Oral Anti-Diabetic Medicines in India

Abbott and MSD Pharmaceuticals (tradename of Merck & Co., Inc., Rahway, N.J., USA) are announcing a strategic collaboration through a distribution agreement for MSD’s oral anti-diabetic medicine, Sitagliptin, its combination, Sitagliptin/Metformin, and the extended-release version in India.

Abbott Introduces TactiFlex™ Sensor Enabled™ Ablation Catheter in India, for Treatment of Abnormal Heart Rhythms

Abbott, the global healthcare company, announced the launch of the TactiFlex™ Sensor Enabled™ Ablation Catheter, the world’s first ablation catheter with a flexible tip and contact force technology.

Abbott Introduces Navitor™ Vision in India, the Next Generation of Heart Valve Technology Designed to Treat Aortic Stenosis

Abbott, the global healthcare company, announced the launch of Navitor Vision in India for the treatment of patients with symptomatic severe aortic stenosis who are at high or extreme surgical risk.

Abbott launches 14 valent Pneumococcal Conjugate Vaccine (PCV-14) That Offers Broadest Protection for Children Against Pneumococcal Bacterial Infections

Abbott, the global healthcare leader, announced today the launch of its Pneumococcal Conjugate Vaccine, PneumoShield 14, for children over 6 weeks of age.

Abbott Launches AVEIR™ VR Leadless Pacemaker System in India to Treat Patients with Slow Heart Rhythms

Abbott, the global healthcare company announced the launch of AVEIR™ VR single-chamber ventricular leadless pacemaker for the treatment of patients in India with slow heart rhythms.

Abbott and the Association of Physicians of India (API) Collaborate to Improve Medication Adherence for Better NCD Management at Abbott’s a:care Congress

Abbott, the global healthcare leader, recently hosted the India chapter of the third edition of a:care Congress in collaboration with the Association of Physicians of India (API).

New Survey from Abbott Finds Epidemiologists Believe Viral and Mosquito-Borne Pathogens are Priority Concerns for Disease Outbreaks

Abbott announced the findings of a new survey among leading infectious disease experts around the world on the state of pandemic preparedness.

Abbott Drives Vertigo Understanding With its New Survey and "Chakkar ko Check Kar" Campaign

Abbott, the global healthcare leader, launched its ‘Chakkar Ko Check Kar’ campaign in India to highlight an often-overlooked balance disorder, vertigo, which affects close to 70 million people in India.

Abbott and YRGCARE Inaugurate New Innovative Outreach Centers in India

Abbott and YRGCARE Inaugurate New Innovative Outreach Centers in India, Offering Testing, Treatment and Support to Help Stop the Spread of HIV and Other Infectious Diseases

Accelerating Automation, Abbott Introduces GLP systems Track for Laboratories in India

Global healthcare leader Abbott announced the launch of its innovative automation solutions, GLP systems Track, to support laboratories’ high-volume needs.

Abbott Launches Next-Generation XIENCE Sierra™ Stent in India, Offering Cardiologists a New Level of Care and Precision

Abbott, the global healthcare company, announced the launch of XIENCE Sierra™ Everolimus (drug) Eluting Coronary Stent System in India.

Abbott Encourages More People to Talk About Menopause, The Next Chapter in a Woman's Life

Global healthcare company Abbott is taking The Next Chapter campaign on menopause a step forward through new ways to break the silence around the topic.

Addressing India’s Blood Shortage, Abbott Launches an Awareness Campaign to Inspire India’s Youth to Donate Blood

While India has progressed considerably, there is still a gap in the country’s requirement of blood supply.

Abbott’s New Coronary Imaging Software Powered by Artificial Intelligence Launched in India

Abbott today announced that it has launched its new vascular imaging platform powered by Ultreon 1.0 Software in India.

Abbott Provides Access to Safe Drinking Water in Government Schools in Baddi

In line with Abbott’s work to improve health equity and overcome disparities in local communities, the global healthcare company is marking World Children’s Day by announcing its water stewardship initiative, aimed at providing access to clean drinking water supply for children from the Government schools in villages around Baddi.

Abbott Launches New PediaSure with Nutri-Pull System to Help Support Catch-Up Growth and Overall Health in Children

Proper nutrition is critical to help children grow and reach their full potential, yet worldwide there are approximately 149 million stunted children below the age of five—and one-third, or 40.6 million, are in India.

Abbott Helps People with Vertigo Take Control of Their Health with the Launch of an Easy-to-Use ‘Vertigo Coach’ App in India

Abbott has launched the ‘Vertigo Coach’ app in India, a digital health solution to help people with vertigo get the information and resources they need to manage their condition holistically, at any time of the day.

Abbott Launches Navitor™, its Latest-Generation Transcatheter Aortic Valve Implantation (TAVI) System to Treat Aortic Stenosis in India

Global healthcare company, Abbott today announced that it has launched its latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor™, making the minimally invasive device available for people in India with severe aortic stenosis who are at high or extreme surgical risk.

Abbott to Upgrade 75 Primary Health Centres Across India, Providing Quality, Accessible Care to 2.5 million People

Global healthcare company Abbott has committed to upgrading 75 Primary Health Centres (PHCs) to Health and Wellness Centres (HWCs) across nine States in India in partnership with Americares India Foundation, a health-focused relief and development organization.

Understanding Menopause – Abbott’s Quality of Life Survey and The Next Chapter Campaign Aim to Help Women Live More Fully

Abbott collaborated with Ipsos to conduct a survey on menopause in India with over 1,200 respondents from seven major cities. Key findings include that more than 87% of respondents believe that menopause can impact a woman’s day-to-day life.

Abbott Launches New Ensure With Hmb To Help Protect And Strengthen Indian Adults’ Muscles

To encourage healthy, holistic growth in kids, Abbott has launched its Grow Right 2.0 charter introducing M-E-A-N-S guidelines for good practices in Measuring growth, Eating, Activity, Nurturing and Sleep.

Abbott Launches Grow Right 2.0 Highlighting the Right M-E-A-N-S to Help Parents Foster Holistic Growth in Children

To encourage healthy, holistic growth in kids, Abbott has launched its Grow Right 2.0 charter introducing M-E-A-N-S guidelines for good practices in Measuring growth, Eating, Activity, Nurturing and Sleep.

Abbott Launches Arachitol Gummies: Bridging the Nutritional Gap for Vitamin D and Calcium

Abbott, the global healthcare leader, has launched Arachitol Gummies in India, a new fruit flavored product for kids and adults. Arachitol Gummies is a dietary supplement that helps maintain required levels of Vitamin D sustainably.

Abbott Announces Collaborations, Reinforces its Commitment Towards Access to Holistic Diabetes Care

Abbott, the global healthcare leader, announced new collaborations with key health-tech partners BeatO, Sugar.fit, PharmEasy, GOQii, 1MG, Zyla Health, Healthifyme and Fitterfly to usher a new era of holistic diabetes management care.

New Research Finds Challenges in Symptom Recognition and Diagnostic Testing can impact Patient Satisfaction for People with Vascular Disease

Abbott today released new global market research from its Beyond Intervention initiative, the company’s multi-year global research program designed to examine the vascular patient experience from the perspectives of patients, physicians and healthcare leaders.

Abbott Launches New PediaSure in India – Latest Innovation to Support Catch-Up Growth and Unlock Growth Potential in Children

Abbott announced the launch of its innovative childhood nutrition solution, the new PediaSure with arginine and natural vitamin K2 to support children's growth and development through proper nutrition.

Abbott Introduces Room-Temperature-Stable, Single-Dose Formulation of Carbetocin for the Prevention of Postpartum Haemorrhage in India

Abbott, the global healthcare company has announced the introduction of a room-temperature-stable, single-dose formulation of carbetocin in India, which is available in convenient vials, to help in the prevention of postpartum haemorrhage (PPH).

Abbott Launches Panbio™ COVID-19 Antigen Self-Test in India; Strengthens Rapid Diagnostics Portfolio to Support Testing Needs at Home, Work and at Clinics

Abbott has announced the launch of Panbio™ COVID-19 Antigen Self-Test for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms. In alignment with the current ICMR advisory on self-use, these tests will be made available to ramp up testing of symptomatic and asymptomatic individuals and contacts of confirmed coronavirus cases.

Abbott Launches New Device in India for Treatment of Premature Babies and Newborns With a Life-threatening Opening in Their Hearts

Abbott, the global healthcare company, has launched its Amplatzer Piccolo™ Occluder in India, the world's first medical device that can be implanted in the tiniest babies (weighing as little as 700 gms) using a minimally invasive procedure to treat patent ductus arteriosus, or PDA.

Abbott’s New Brufen® Power Spray Film Highlights the 'Power of Targeted Pain Relief'

Abbott, the global healthcare leader, has unveiled a digital film and television commercial (TVC) to launch its new Brufen Power spray, an in-house innovation that addresses the need for a targeted solution to address physical pain.

Abbott Announces its Pandemic Defence Coalition: A Global Network of Expert Collaborators Designed To Help Prevent Future Pandemics, Currently Searching for COVID-19 Variants

We've launched the Abbott Pandemic Defense Coalition, aiming to help prevent viral threats from reaching pandemic levels and identify new COVID-19 variants.

Abbott Researchers Find Rare Group of People With Controlled HIV Who Could Be a Key To Unlocking Cure

A large group known as HIV controllers has been identified by Abbott Virus Hunters in the Democratic Republic of Congo. They may help us understand natural HIV suppression.

Abbott Strengthens Structural Heart Portfolio with New Clip Delivery System

Abbott, the global healthcare company, has launched its clip delivery system, a minimally invasive heart valve repair device to treat mitral regurgitation in India. This product puts new technology into the hands of physicians by giving them a life-saving treatment option that may be used for people suffering from mitral regurgitation due to a heart defect or as a result of heart failure.

Abbott’s Once-A-Day Ivabradine Receives DCGI Approval for Heart Failure and Angina patients

Approval marks the first once-a-day formulation for Ivabradine in India, which will help increase adherence to therapy for chronic heart failure and chronic stable angina

Abbott and 1mg Bring Continuous Glucose Monitoring Solutions Closer to Indian homes

In a move to expand access and empower Indian patients to take charge of their health, Abbott and leading online pharmacy and healthcare platform, 1mg today announced their collaboration to make Abbott’s continuous glucose monitoring products available online, including its professional flash glucose monitoring system, FreeStyle® Libre Pro. Patients in India can upload a healthcare practitioner’s prescription and purchase the product online on 1mg.

FreeStyle® Libre System in India Providing Real-time Continuous Glucose Monitoring for People with Diabetes

ABBOTT LAUNCHES REVOLUTIONARY FREESTYLE® LIBRE SYSTEM IN INDIA PROVIDING REAL-TIME CONTINUOUS GLUCOSE MONITORING FOR PEOPLE WITH DIABETES

Abbott to Supply More Than a Million Tests of IgG Lab-based Antibody Tests to India

Abbott announced today that it has begun supply of its laboratory-based serology blood test for the detection of the antibody, IgG (Immunoglobulin G), that identifies if a person has had the novel coronavirus (COVID-19).

COVID-19 laboratory-based antibody test in India

Abbott announced today it received CE Mark to the IVD Directive (98/79/EC) for its laboratory-based serology blood test for the detection of the antibody, IgG, that identifies if a person has had the novel coronavirus (COVID-19). Antibody testing is an important next step to tell if someone has been previously infected. It will provide more understanding of the virus including how long antibodies stay in the body and if they provide immunity. This type of knowledge could help support the development of treatments and vaccines.

Apollo Hospitals and Abbott Join Forces

Cardiovascular diseases (CVDs) are the biggest cause of mortality in India with nearly 25 percent of mortalities – amongst the age group of 25 to 69 years – attributed to CVDs. The condition also seems to affect Indians at least a decade earlier as compared to Europeans.

Abbott expands cardiac arrhythmias

Abbott today announced the launch of its HD grid mapping catheter, which is sensor enabled in India. This product received USFDA clearance last year in May. The catheter employs a new design that allows physicians to see things differently, capturing and analyzing data in a novel manner to create highly detailed maps of the heart that better differentiate healthy from unhealthy tissue.

New Research Finds Physicians and Patients Point to Emerging Technology and Data as Central to Closing Treatment Gaps and Improving Vascular Health

Abbott today announced the launch of its HD grid mapping catheter, which is sensor enabled in India. This product received USFDA clearance last year in May. The catheter employs a new design that allows physicians to see things differently, capturing and analyzing data in a novel manner to create highly detailed maps of the heart that better differentiate healthy from unhealthy tissue.

A Care_PressRelease_INDIA

A Care_PressRelease_INDIA_19.03.2019

Abbott and Malaria No More Work Together to End Malaria in Odisha, India

Abbott to supply rapid diagnostic tests critical for malaria detection and surveillance, technical expertise and funding support. Initiative focuses on Odisha, the state with the highest burden of malaria in India

ABBOTT HELPS TO SIMPLIFY DIABETES THROUGH ITS REAL HEROES 2.0 CAMPAIGN

A new survey conducted by Abbott in mothers of pre-term babies, calls for heightened focus on nutrition and the need for counselling of mothers with pre-term* babies, equipping them to bring up healthier babies.

Abbott’s New PediaSure® Cookies & Cream ensures Summer Break is a good #timetogrow for Children

Abbott’s New PediaSure® Cookies & Cream ensures Summer Break is a good #timetogrow for Children

Abbott’s influenza survey aims to help moms understand the need to fight the flu

Abbott, one of India’s leading healthcare companies, recently conducted a perception survey on influenza to assess the awareness, usage and attitudes towards influenza immunizaton.

22% of Indian adults suffer from constipation : Abbott 'Gut Health Survey'

Abbott’s nationwide survey Gut Health Survey to better understand the factors impacting the country’s gut health and the connections between metabolic disorders and gut health.

Abbott and YRGCARE Announce Unique Collaboration to Study HIV and Viral Hepatitis Patterns in India

Strengthening India’s efforts in combating HIV and hepatitis viruses, Abbott has announced its partnership with Y.R. Gaitonde Centre for AIDS Research and Education (YRGCARE) to study the country’s viral diversity to improve accuracy of diagnostic tests.

Abbott launches first Smartphone Compatible Insertable Cardiac Monitor to Detect Arrhythmias

The world's first smartphone compatible ICM to help physicians identify even the most difficult to detect cardiac arrhythmias, including atrial fibrillation (AF), in order to help guide appropriate therapy

Abbott’s ‘Quality of Survival’ Survey Finds Counselling for Mothers on Nutrition and Care Has a Positive Impact on Pre-Term Babies’ Health

A new survey conducted by Abbott in mothers of pre-term babies, calls for heightened focus on nutrition and the need for counselling of mothers with pre-term* babies, equipping them to bring up healthier babies.

Abbott Pioneers New Liquid Dosing Device, LiDoCon, in India

Conceptualized at Abbott’s Innovation and Development Center in Mumbai; LiDoCon - short for Liquid Dosing Concept - a first of its kind device for liquid medicines that provides accurate, hygienic and convenient dosing. This concept is a first of its kind in India.

Abbott Increases Access of Widest Nutrition Portfolio for Rare Metabolic Disorders in India

Collaboraion with healthcare providers, nutritionists and government allows for immediate availability, ensuring faster access to babies in need of critical nutrition

New Study Results May Lead to a New Standard of Care for In Vitro Fertilization Treatment

Oral dydrogesterone has the potential to become new treatment of choice for an estimated 1.5 million women worldwide who undergo ivf treatment each year

Abbott Gut Health Survey

‘Abbott Gut-Health Survey’ Shows that 14% of People in Urban India Suffer from Chronic Constipation

First Flash Glucose Monitoring System

First-of-its-Kind Flash Glucose Monitoring System from Abbott to Revolutionize Diabetes Management in India

Liver Health and Raising Hepatitis C Awareness

Abbott Launches Initiative for Diagnosis of Liver Health and Raise Hepatitis C Awareness in India

Thyroid Awareness

Indian Thyroid Society (ITS) and Abbott to Help Raise Awareness of Thyroid Conditions across Coastal Andhra Pradesh

Road Safety Awareness

American Association of Physicians of Indian Origin (AAPI) and Amitabh Bachchan Join Hands with Abbott to Drive Road Safety Awareness

Abbott Sugar Survey

‘Abbott Sugar Survey’ Shows 9 out Of 10 People with Uncontrolled Diabetes Believe their Blood Sugar is Actually Under Control

SHOWING 1 - 25 OF 59

59

25

© 2025 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.